Testosterone Cost Guide By Delivery System
The following guide shows the average cost ranges for different testosterone delivery systems without insurance:
Injections – Testosterone injections tend to cost less than most other methods, and can range from as little as $40 a month to as high as $200 depending on dosage and frequency of injections.
Oral Tablets – Oral tablets by prescription can cost between $100 for smaller, less frequent doses, to $300 a month for higher dosage and frequency.
Gels & Creams – Topical gels and creams normally cost between $200 and $500 a month and are again dependent on dosage and concentration.
Patches – Dermal adhesive patches are about on par with gels and creams, costing between $200 and $500 a month on average.
Gum & Cheek – Materials that adhere to the gums or inside the cheek also tend to cost around $200-$500 per month.
Again, this guide is based on the national average, which does not account for local pricing levels, which could affect cost substantially in either direction.
ATRS used to say a partnership to market Otrexup in the EU was a 12 - 18 month goal. They quit even mentioning Otrexup in the EU if that tells you something.
Europeans are smart enough to know an injector is really an expensive gimmick for a SQ injection. Basic pre-filled syringes dominant the EU market.
Can you point me to the name of a hedge fund where I can put in my application as a basher? I'd make a heck of a lot more with the $5 responses then you are investing in the stock.
Google - "FDA drug approvals 2014" - Click on the first link & look for Rasuvo - If Medac got tentative approval it would say so instead of approval.
They got full approval. ATRS can sue them but it won't stop Medac from marketing their drug & its going to take years to settle the claims.
Pjmyers, it looks like companies can use the 505(b)(2) approval process, design their own injectors, & circumvent the patents. If companies file as a generic then ATRS could probably block their efforts for years. I didn't think it was possible a few weeks ago but the lawyers are saying differently.
ATRS can't stop Medac from marketing Rasuvo & the patent case will be tied up in the courts for years. ATRS lost the battle.
I initially said Medac had a plan or they wouldn't be spending millions on Rasuvo's development but then I decided ATRS's patents would block approval. I was wrong but I should have known this since ATRS has screwed up everything they've ever touched.
revenues cut by about 60%? I figure Medac takes half the market & then we need to reduce the estimates due to pricing pressures.
rheumatologists & approval by insurance carriers & now their going to get shafted. If you think the first to market will prevent Medac from taking market share then your kidding yourself. Medac will undercut ATRS pricing & I heard their only hiring single female sales personnel with big boobs. We're screwed.
shark infested waters. Sold the shares I purchased today & I'll never buy another share.
No, the volume is to small to throw out a 20K bid. Looks like we'll have to wait for Monday to see if the stock can gain some traction.